Skip to content
Dr Agarwals Eye Hospital logo

Dr Agarwals Eye Hospital

DRAGARWQ NSE
₹5,140.00 up 28.00 (0.55%)
Market Cap
₹2,484 Cr
P/E
32.59

Dr Agarwals Eye Hospital (DRAGARWQ) share price was ₹5,112.00 at the 28 Oct 2026 close; market capitalisation ₹2,471 Cr; P/E (TTM) 32.41; sector Healthcare Services. The share price fell 1.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 22.3% year on year to ₹143.0 Cr and net profit rose 35.3% year on year to ₹23.4 Cr (compared with Jun 2025). Promoters held 72.67% of Dr Agarwals Eye Hospital in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 56/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹5,112.00 +11.55 +0.23% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹2,484 Cr
P/E (TTM)
32.59
EBITDA
₹151 Cr
Return on Equity
20.24%
Debt to Equity
0.94
Book Value
₹716.56
EPS (TTM)
₹157.72
52W High
₹6,392.00
52W Low
₹4,412.05

Price-based figures as of 29 Oct 2026, 10:43 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Apollo Hospitals
₹8,227.0056.611,18,292 Cr12.480.26%20.08%19.79%26,675 Cr2,171 Cr
Manipal Health Enterprises
₹638.8085.1784,026 Cr5.110.00%10.42%9.50%11,400 Cr906 Cr
Max Healthcare Institute
₹862.0557.5583,904 Cr7.810.24%13.42%12.70%8,879 Cr1,457 Cr
Aster DM Healthcare
₹677.95110.2459,095 Cr14.050.45%8.84%9.71%5,006 Cr363 Cr
Fortis Healthcare
₹756.4554.5057,109 Cr5.770.14%10.47%12.13%9,607 Cr1,070 Cr
Narayana Hrudayalaya
₹1,710.7042.8334,960 Cr7.700.26%17.85%11.39%9,185 Cr816 Cr
Global Health
₹1,300.0062.8334,953 Cr8.820.04%13.91%15.05%4,800 Cr552 Cr
Dr Agarwals Eye Hospital (this company)
₹5,140.0032.592,484 Cr7.170.13%20.24%16.10%504 Cr75 Cr
Median 8 companies₹1,081.0357.0858,102 Cr7.760.19%13.67%12.42%9,032 Cr861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

56 Good
Overall score

Data confidence 100/100

Category scores

Quality Strong 81
Returns, margins, earnings quality 22% weight
Valuation Weak 44
Cheap vs sector & own history 24% weight
Growth Strong 70
Sales & profit trajectory 9% weight
Financial Health Poor 35
Solvency, leverage, coverage 9% weight
Momentum Weak 38
Trend strength, vol-adjusted 12% weight
Ownership Good 63
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has delivered good profit growth of 118% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.2%

Weaknesses

2
  • Stock is trading at 7.28 times its book value
  • Company might be capitalizing the interest cost

Technical Indicators

Oscillators

Neutral

Bearish
1
Neutral
7
Bullish
1

Overall

Bearish

Bearish
8
Neutral
7
Bullish
4

Moving Averages

Bearish

Bearish
7
Neutral
0
Bullish
3

Analyst Rating

Based on 1 analysts
BUY100%

1 of 1 analyst rates Buy, 0 Hold, 0 Sell.

Updated 29 Oct 2026

BUY
1
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

Revenue Growth
18.52% lower than 3Y

change over 1 year

Net Income Growth
28.39% higher than 3Y

change over 1 year

Cash Flow Change
55.13%

change over 1 year

EBITDA Margin Change
3.16%

change over 1 year Operating margin 30% · Jun 2026

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹706 Cr
Reported High Mean Low

Analyst consensus here uses a different definition from reported ebitda (they differ 3.7× on periods where both exist), so the forecast is shown on its own rather than joined to the reported line.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
79
84
76
81
100
102
95
100
117
118
116
120
143
Expenses
56
61
55
56
69
72
69
68
80
78
82
86
100
Operating Profit
23
23
21
24
31
30
26
32
37
40
34
34
43
OPM %
29%
28%
27%
30%
31%
29%
27%
32%
32%
34%
30%
28%
30%
Other Income
0
1
1
2
0
2
2
0
1
1
3
2
2
Interest
2
2
2
2
3
4
4
3
4
4
2
2
3
Depreciation
6
6
7
8
10
9
10
10
11
11
12
12
11
PBT
16
17
13
17
19
19
14
19
23
26
23
21
31
Tax %
26%
24%
26%
26%
25%
26%
26%
14%
26%
25%
26%
24%
24%
Net Profit
12
13
9
13
14
14
10
16
17
19
17
16
23
EPS (₹)
24.55
26.79
20.09
27.21
30.02
30.11
22.13
34.02
36.72
39.98
35.76
33.6
48.38
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
118
137
149
153
170
176
140
201
268
319
397
471
497
Expenses
103
119
126
129
140
129
109
143
192
227
277
324
345
Operating Profit
15
18
23
24
30
47
31
59
76
92
120
147
151
OPM %
13%
13%
15%
16%
18%
27%
22%
29%
28%
29%
30%
31%
30%
Other Income
0
-5
1
2
2
3
1
1
2
5
5
6
7
Interest
4
5
4
3
4
9
7
7
8
8
15
14
10
Depreciation
6
9
9
10
11
21
19
20
20
27
39
46
47
PBT
5
0
11
13
17
20
6
32
49
62
71
94
101
Tax %
-6%
-104%
33%
49%
32%
31%
125%
25%
25%
26%
23%
25%
—
Net Profit
6
0
7
7
12
14
-1
24
37
46
55
70
76
EPS (₹)
12.13
0.09
15.62
14.43
25.36
29.11
-3.06
51.28
78.55
98.64
116
145
158
Div. Payout %
10%
940%
10%
8%
6%
0%
0%
6%
4%
3%
5%
5%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5
5
5
5
5
5
5
5
5
5
5
5
Reserves
19
19
25
30
41
51
50
73
109
152
205
341
Borrowings
27
31
23
18
24
60
68
193
232
268
333
326
Other Liabilities
18
24
20
28
31
24
33
42
44
71
71
94
Total Liabilities
69
79
72
81
100
141
155
314
390
496
613
766
Fixed Assets
26
34
33
36
55
94
96
214
260
316
393
403
CWIP
0
1
1
3
0
0
0
26
62
97
128
197
Investments
0
0
0
0
0
0
0
0
0
0
13
89
Other Assets
43
44
38
42
45
47
60
73
67
83
80
78
Total Assets
69
79
72
81
100
141
155
314
390
496
613
766
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
17
20
19
25
39
34
57
70
90
94
145
Investing
-10
-17
-8
-11
-25
-17
-11
-46
-71
-70
-133
-174
Financing
-5
0
-12
-8
2
-20
-8
-4
0
-14
17
25
Net Cash Flow
-1
0
0
0
2
2
15
7
-1
6
-23
-4
Free Cash Flow
3
1
12
7
0
22
23
10
-1
19
-9
47
CFO/OP
106
113
103
98
111
96
120
112
107
112
95
105
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
19
24
16
17
19
14
23
16
14
15
13
14
Inventory Days
238
200
123
148
124
132
117
91
73
106
55
51
Days Payable
360
371
277
353
292
224
401
410
327
345
101
97
Cash Conversion Cycle
-103
-146
-138
-189
-149
-78
-260
-303
-240
-224
-34
-31
Working Capital Days
-31
-39
-25
-39
-22
-34
-70
-58
-50
-63
-51
-55
ROCE %
19%
18%
29%
32%
34%
30%
11%
20%
19%
18%
18%
17%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Dr Agarwals Eye Hospital insights

62 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

FIIs2.22%Promot.72.67%DIIs2.54%Others4.99%Public17.58%As ofSep 2026

Documents

1
Concall - Aug 2025 Aug 2025
2
Concall - Nov 2023 Nov 2023
3
Concall - May 2023 May 2023
4
Concall - May 2023 May 2023
5
Concall - Feb 2023 Feb 2023

Frequently Asked Questions about Dr Agarwals Eye Hospital

What does Dr Agarwals Eye Hospital Ltd do?
Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]
Where is Dr Agarwals Eye Hospital Ltd (DRAGARWQ) listed?
Dr Agarwals Eye Hospital Ltd trades as DRAGARWQ on the NSE and under code 526783 on the BSE.
Which sector does Dr Agarwals Eye Hospital Ltd belong to?
Dr Agarwals Eye Hospital Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd has a market capitalisation of ₹2,484 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd trades at a PE ratio of 32.59 as of 29 Oct 2026, on earnings per share of ₹157.72, against a book value of ₹716.56 per share.
What is the 52-week high and low of Dr Agarwals Eye Hospital Ltd?
Over the last 52 weeks Dr Agarwals Eye Hospital Ltd has traded between ₹4,412.05 and ₹6,392 as of 29 Oct 2026.
Does Dr Agarwals Eye Hospital Ltd pay dividends?
Dr Agarwals Eye Hospital Ltd has a dividend yield of 0.14%.
What is the Return on Equity (ROE) of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd reported a return on equity of 20.24%. Its debt-to-equity ratio is 0.94.

Company Information

Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]

Website dragarwal.com
Listed 2001-08-13
Face Value ₹ 10
Shares Outstanding 48,32,827

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526783.md for Dr Agarwals Eye Hospital Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month